Basis of Presentation and Significant Accounting Policies Supplemental Cash Flow Information (Tables)

12 Months Ended

Dec. 31, 2025

Statement of Cash Flows [Abstract]

Schedule of Supplemental Cash Flow Information [Table Text Block]

Income taxes paid, net of refunds, exceeds 5% of total income taxes paid, net of refunds, in the following jurisdictions:

Year Ended December 31,	2025		2024		2023
State
Texas	$	24	$	18	$	—
Foreign
United Kingdom	5,528		508		—
Total	$	5,552	$	526	$	—

Cash Flow, Supplemental Disclosures [Text Block]

Supplemental information related to leases is as follows:

Year Ended December 31,	2025		2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	11,060	$	4,432	$	4,155
Right-of-use assets obtained in exchange for operating lease liabilities (non-cash)	8,761		2,256		714

Redeemable Noncontrolling Interest

Following is a rollforward of redeemable NCI.

Years ended December 31,	2025		2024
Beginning balance	$	199,402	$	17,079
Net income (loss) attributable to redeemable noncontrolling interest (ASC 810)	(2,007)		(1,282)
Gain (loss) on foreign currency translation attributable to redeemable NCI	15,227		(4,805)
Fair value of acquired redeemable noncontrolling interest at acquisition date	1,359		185,469
Reclassification from nonredeemable noncontrolling interest including remeasurement at fair value	42,180		—
Reclassification to nonredeemable noncontrolling interest	(5,136)		—
Put / call option exercise	(1,815)		—
Distributions	(4,128)		(2,391)
Adjustment to redemption value (ASC 480)	7,899		5,332
Ending Balance	$	252,981	$	199,402

The following table outlines the aggregate amounts of redeemable NCI according to the next earliest year in which a NCI put option becomes exercisable over the next five years as of December 31, 2025:

2026	$	69,387
2027	77,002
2028	55,309
2029	48,833
2030	2,450
Total	$	252,981

Per ASC 480, the redeemable NCI is to be recorded as the greater of the carrying value or redemption value, therefore, the options in any issue year could be exercised at a lower amount.

Schedule of Error Corrections and Prior Period Adjustments

Corrected Consolidated Balance Sheet:

	Year Ended December 31, 2024
	As Reported		Immaterial Correction		As Corrected
Redeemable noncontrolling interest	$	140,860	$	58,542	$	199,402
Retained earnings	742,185		(58,542)		683,643
Total liabilities, redeemable noncontrolling interest and stockholders' equity	$	8,058,378	$	—	$	8,058,378

Corrected Consolidated Statement of Stockholders’ Equity:

	Year Ended December 31, 2024
	As Reported	Immaterial Correction	As Corrected
Retained earnings	742,185	(58,542)	683,643

Corrected Earnings Per Share:

	Year Ended December 31, 2024
	As Reported		Immaterial Correction		As Corrected
Net income (loss) from continuing operations per share attributable to stockholders
Basic	$	(0.13)	$	(1.24)	$	(1.37)
Diluted	$	(0.13)	$	(1.24)	$	(1.37)
Net income (loss) per share attributable to shareholders
Basic	$	(10.71)	$	(1.25)	$	(11.96)
Diluted	$	(10.71)	$	(1.25)	$	(11.96)

Corrected rollforward of redeemable NCI:

	Year Ended December 31, 2024
	As Reported		Immaterial Correction		As Corrected
Beginning balance	$	17,079	$	—	$	17,079
Fair value of redeemable NCI at acquisition date	185,469		—		185,469
Net income attributable to redeemable NCI (ASC 810)	(1,282)		—		(1,282)
Distributions	(2,391)		—		(2,391)
Adjustment to redemption value (ASC 480)	(53,210)		58,542		5,332
Foreign exchange	(4,805)		—		(4,805)
Ending balance	$	140,860	$	58,542	$	199,402